Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jul 7, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment aimed at improving heart rate variability (HRV) to help people who continue to experience symptoms long after a mild traumatic brain injury, such as a concussion. These ongoing symptoms—called persistent post-concussion symptoms—can include headaches, dizziness, trouble thinking or remembering, sleep problems, and mood changes like irritability or depression. The study focuses on veterans and service members who have had at least one mild brain injury more than a year ago and are still dealing with significant symptoms that affect their daily lives. Researchers believe that problems with the autonomic nervous system, which controls things like heart rate and stress responses, may be keeping these symptoms going, and improving HRV could help.
If you are 18 or older, have served in the military, and have had a mild brain injury with ongoing symptoms like sleep difficulties, you might be eligible to join. Participants will be asked to take part in the treatment and monitoring, which involves measuring heart rate changes over time to see if the therapy helps improve symptoms. The study is currently recruiting adults of all genders who speak English and can provide informed consent. People with more severe brain injuries, certain heart conditions or devices, a history of stroke, or mental health issues that could make it hard to follow the study plan are not eligible. This trial offers a chance to explore a new way to manage long-lasting effects of concussion, especially in those who have served in the military.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18 or older
- • History of military service
- • Self-Reported hx of 1 or more mild TBI
- • Most recent TBI more than 1 year ago
- • Significant Persistent Post-Concussion Symptom burden (Neurobehavioral Symptom Inventory \[NSI\] total score greater than or equal to 20).
- • Current Sleep Difficulties
- • Fluent English
- • Able to provide Informed Consent
- Exclusion Criteria:
- • Any TBI with severity greater than mild (i.e., Moderate or Severe TBI defined as initial injury loss of consciousness (LOC) duration \>30 minutes, posttraumatic amnesia (PTA) duration \>24 hours, or traumatic hemorrhage on head computerized tomography (CT) and determined by the study investigator based on information gathered during administration of the study's validated TBI structured interview instrument.
- • Conditions or medications that can affect HRV measurement (pacemaker or an implant that stimulates your heart (e.g., cardioverter-defibrillator or ICD); heart transplant or heart surgery within the last year, including bypass or other surgery, but not including a stent)
- • Hx of stroke
- • Mental conditions that may impede adherence (e.g., dementia, psychotic disorder, panic disorder)
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
James Burch
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported